SEED Co.,Ltd. Financial Summary for the Second Quarter (Interim) of the Fiscal Year Ending March 2027

Overview of Results

In the second quarter of this fiscal year, net sales were 18,132 million yen, operating income was 1,413 million yen, ordinary income was 1,030 million yen, and interim net income attributable to owners of parent was 528 million yen. Sales increased 5.8% year-over-year, but interim net income declined by approximately 44% year-over-year due to recording tender-offer-related expenses of 196 million yen as a special loss. The contact lenses and care products segment remained the core business, with increased sales of higher-value-added lenses such as toric and multifocal lenses contributing to results. A revision of goodwill valuation related to the business combination, reflecting finalized accounting, also had an impact.

Outlook and Key Matters

The full-year earnings forecast published is net sales of 37,000 million yen, operating income of 2,200 million yen, and net income of 1,350 million yen; however, special losses such as tender-offer-related expenses may affect interim results. Finalization of provisional accounting for the business combination conducted as of December 2026 has resulted in adjustments to goodwill and asset valuations, which may affect future performance. Through the Ocudevices-related business integration, the company will continue to strengthen sales, primarily in Asia.